# OnCo record co-17 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/co-17/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "co-17", "NCT00079066" ;
  schema:name "NCIC CO.17"@en ;
  schema:alternateName "CO.17"@en ;
  schema:description "The trial that proved an EGFR antibody on its own lengthens life in bowel cancer, and whose stored tumour blocks then proved that only KRAS-normal tumours benefit."@en ;
  schema:url <https://onco.cc/trials/co-17/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00079066>, <https://doi.org/10.1056/NEJMoa071834> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/> ;
  onco:companies <https://onco.cc/companies/cctg/> ;
  onco:trials <https://onco.cc/trials/crystal-fire3/>, <https://onco.cc/trials/prime/>, <https://onco.cc/trials/opus/> .